Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 78 | 2024 | 3733 | 9.710 |
Why?
|
Antirheumatic Agents | 19 | 2024 | 1363 | 3.650 |
Why?
|
Electronic Health Records | 44 | 2024 | 4862 | 2.950 |
Why?
|
Natural Language Processing | 17 | 2023 | 1198 | 2.830 |
Why?
|
International Classification of Diseases | 8 | 2020 | 933 | 1.720 |
Why?
|
Inflammatory Bowel Diseases | 12 | 2019 | 2429 | 1.550 |
Why?
|
Biological Products | 6 | 2024 | 942 | 1.510 |
Why?
|
Cardiovascular Diseases | 28 | 2024 | 15648 | 1.470 |
Why?
|
Coronary Circulation | 7 | 2024 | 1602 | 1.470 |
Why?
|
Peptides, Cyclic | 9 | 2017 | 390 | 1.420 |
Why?
|
Algorithms | 34 | 2024 | 14061 | 1.350 |
Why?
|
Troponin T | 3 | 2024 | 785 | 1.320 |
Why?
|
Rheumatology | 6 | 2024 | 602 | 1.210 |
Why?
|
Chondrocalcinosis | 2 | 2021 | 84 | 1.200 |
Why?
|
Microcirculation | 3 | 2024 | 1280 | 1.180 |
Why?
|
C-Reactive Protein | 7 | 2024 | 3850 | 1.160 |
Why?
|
Cholesterol, LDL | 8 | 2021 | 2393 | 1.130 |
Why?
|
Colitis, Ulcerative | 8 | 2019 | 1915 | 1.100 |
Why?
|
Autoantibodies | 12 | 2018 | 2112 | 1.090 |
Why?
|
Crohn Disease | 8 | 2019 | 2283 | 1.060 |
Why?
|
Lipids | 6 | 2024 | 3315 | 1.050 |
Why?
|
Phenotype | 22 | 2024 | 16706 | 1.000 |
Why?
|
Methotrexate | 6 | 2024 | 1721 | 0.950 |
Why?
|
Rheumatoid Factor | 6 | 2024 | 183 | 0.910 |
Why?
|
Coronary Artery Disease | 12 | 2024 | 6545 | 0.910 |
Why?
|
Inflammation | 12 | 2024 | 10846 | 0.840 |
Why?
|
Rheumatic Diseases | 3 | 2024 | 622 | 0.790 |
Why?
|
Spondylarthritis | 2 | 2020 | 62 | 0.790 |
Why?
|
Sjogren's Syndrome | 2 | 2014 | 239 | 0.770 |
Why?
|
Spondylitis, Ankylosing | 2 | 2020 | 157 | 0.760 |
Why?
|
Coronary Vessels | 5 | 2024 | 3097 | 0.740 |
Why?
|
Lipoproteins, HDL | 2 | 2017 | 674 | 0.740 |
Why?
|
Drug Substitution | 1 | 2024 | 292 | 0.730 |
Why?
|
Information Storage and Retrieval | 4 | 2019 | 832 | 0.720 |
Why?
|
Hydroxychloroquine | 2 | 2024 | 430 | 0.700 |
Why?
|
Hyperlipidemias | 4 | 2018 | 770 | 0.700 |
Why?
|
Veterans | 4 | 2024 | 2663 | 0.670 |
Why?
|
Polymorphism, Single Nucleotide | 16 | 2024 | 16041 | 0.620 |
Why?
|
Genetic Association Studies | 5 | 2024 | 2740 | 0.620 |
Why?
|
Dyslipidemias | 3 | 2015 | 869 | 0.610 |
Why?
|
Humans | 151 | 2024 | 765734 | 0.610 |
Why?
|
Data Mining | 2 | 2021 | 562 | 0.600 |
Why?
|
Genetic Predisposition to Disease | 17 | 2024 | 18061 | 0.600 |
Why?
|
Calcium Pyrophosphate | 1 | 2018 | 55 | 0.590 |
Why?
|
Vitamin D | 5 | 2015 | 3272 | 0.580 |
Why?
|
Myocardial Ischemia | 3 | 2023 | 2129 | 0.550 |
Why?
|
Middle Aged | 66 | 2024 | 222903 | 0.550 |
Why?
|
Gastrointestinal Agents | 3 | 2018 | 510 | 0.550 |
Why?
|
Lupus Erythematosus, Systemic | 4 | 2021 | 2155 | 0.530 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2022 | 4352 | 0.530 |
Why?
|
Arthrography | 2 | 2014 | 148 | 0.530 |
Why?
|
Gout | 1 | 2023 | 620 | 0.520 |
Why?
|
Interleukin-1 | 2 | 2023 | 1243 | 0.510 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2137 | 0.510 |
Why?
|
Receptors, Interleukin-6 | 3 | 2024 | 226 | 0.510 |
Why?
|
Male | 78 | 2024 | 363585 | 0.490 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2021 | 1736 | 0.480 |
Why?
|
Risk Factors | 39 | 2024 | 74831 | 0.480 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5891 | 0.470 |
Why?
|
Drug Therapy, Combination | 2 | 2024 | 6307 | 0.470 |
Why?
|
Female | 80 | 2024 | 395961 | 0.470 |
Why?
|
Lipoproteins, LDL | 2 | 2019 | 643 | 0.460 |
Why?
|
Fibrinogen | 1 | 2018 | 896 | 0.460 |
Why?
|
Arthralgia | 1 | 2018 | 456 | 0.460 |
Why?
|
Blood Sedimentation | 2 | 2019 | 233 | 0.450 |
Why?
|
Vitamin D Deficiency | 2 | 2013 | 1349 | 0.440 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 938 | 0.440 |
Why?
|
Aged | 47 | 2024 | 171050 | 0.440 |
Why?
|
Risk Assessment | 11 | 2022 | 24279 | 0.430 |
Why?
|
Genome-Wide Association Study | 11 | 2024 | 12800 | 0.430 |
Why?
|
Hospitalization | 7 | 2022 | 10806 | 0.420 |
Why?
|
Joints | 1 | 2014 | 321 | 0.410 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 297 | 0.410 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 177 | 0.390 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2024 | 669 | 0.380 |
Why?
|
Cohort Studies | 22 | 2022 | 41631 | 0.370 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2736 | 0.370 |
Why?
|
Antibodies, Antinuclear | 1 | 2013 | 340 | 0.370 |
Why?
|
Arteritis | 2 | 2024 | 159 | 0.370 |
Why?
|
Peptide Fragments | 2 | 2021 | 5125 | 0.370 |
Why?
|
Hand Joints | 1 | 2011 | 58 | 0.350 |
Why?
|
Prognosis | 15 | 2022 | 29899 | 0.350 |
Why?
|
Epitopes | 1 | 2017 | 2523 | 0.350 |
Why?
|
Parturition | 1 | 2014 | 453 | 0.350 |
Why?
|
Immunologic Factors | 3 | 2022 | 1585 | 0.340 |
Why?
|
Vasodilation | 1 | 2014 | 970 | 0.340 |
Why?
|
Depressive Disorder | 2 | 2013 | 3712 | 0.340 |
Why?
|
Adult | 47 | 2024 | 222974 | 0.330 |
Why?
|
Cholesterol, HDL | 2 | 2019 | 1811 | 0.330 |
Why?
|
Anterior Compartment Syndrome | 1 | 2008 | 8 | 0.320 |
Why?
|
Lipoproteins | 1 | 2013 | 866 | 0.310 |
Why?
|
Apolipoprotein A-I | 3 | 2021 | 304 | 0.310 |
Why?
|
Apolipoproteins B | 3 | 2021 | 384 | 0.300 |
Why?
|
Area Under Curve | 4 | 2020 | 1639 | 0.300 |
Why?
|
Myocardium | 1 | 2021 | 4763 | 0.300 |
Why?
|
Heart Diseases | 1 | 2021 | 2820 | 0.300 |
Why?
|
Hypothyroidism | 1 | 2013 | 665 | 0.290 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2657 | 0.290 |
Why?
|
Early Diagnosis | 2 | 2009 | 1185 | 0.280 |
Why?
|
Thromboembolism | 1 | 2014 | 1003 | 0.280 |
Why?
|
Quality Improvement | 2 | 2020 | 3854 | 0.280 |
Why?
|
Delivery, Obstetric | 1 | 2014 | 946 | 0.280 |
Why?
|
Atherosclerosis | 1 | 2023 | 3425 | 0.280 |
Why?
|
Clostridium Infections | 1 | 2014 | 564 | 0.270 |
Why?
|
Semantics | 2 | 2022 | 609 | 0.270 |
Why?
|
Disease Progression | 6 | 2021 | 13614 | 0.260 |
Why?
|
Cholesterol | 4 | 2021 | 2898 | 0.260 |
Why?
|
Colonoscopy | 1 | 2014 | 1406 | 0.260 |
Why?
|
Colorectal Neoplasms | 3 | 2016 | 6952 | 0.260 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2021 | 64 | 0.260 |
Why?
|
Sulfasalazine | 2 | 2024 | 85 | 0.260 |
Why?
|
Medical Informatics | 1 | 2013 | 743 | 0.260 |
Why?
|
Cesarean Section | 1 | 2014 | 1431 | 0.250 |
Why?
|
Antibodies | 2 | 2014 | 2416 | 0.240 |
Why?
|
HLA Antigens | 3 | 2023 | 1338 | 0.240 |
Why?
|
Follow-Up Studies | 13 | 2019 | 39180 | 0.240 |
Why?
|
Incidence | 13 | 2024 | 21478 | 0.220 |
Why?
|
Synovial Membrane | 2 | 2024 | 513 | 0.220 |
Why?
|
Inflammation Mediators | 3 | 2024 | 1885 | 0.220 |
Why?
|
Genotype | 8 | 2023 | 13024 | 0.210 |
Why?
|
Blood Pressure | 2 | 2018 | 8533 | 0.210 |
Why?
|
Psoriasis | 2 | 2021 | 919 | 0.200 |
Why?
|
Cleft Palate | 1 | 2008 | 592 | 0.200 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2024 | 345 | 0.200 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 36 | 0.200 |
Why?
|
Sigmoid Neoplasms | 1 | 2022 | 54 | 0.200 |
Why?
|
Interleukin-6 | 2 | 2023 | 3229 | 0.190 |
Why?
|
Alleles | 7 | 2023 | 6893 | 0.190 |
Why?
|
Unified Medical Language System | 2 | 2019 | 88 | 0.190 |
Why?
|
Janus Kinases | 1 | 2023 | 253 | 0.190 |
Why?
|
Logistic Models | 7 | 2019 | 13261 | 0.190 |
Why?
|
Sickle Cell Trait | 1 | 2022 | 86 | 0.190 |
Why?
|
Heart Failure | 2 | 2022 | 11840 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 12238 | 0.180 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 14637 | 0.180 |
Why?
|
Triglycerides | 2 | 2021 | 2441 | 0.180 |
Why?
|
Risk | 4 | 2018 | 9592 | 0.180 |
Why?
|
Registries | 4 | 2022 | 8293 | 0.180 |
Why?
|
Case-Control Studies | 13 | 2021 | 22224 | 0.170 |
Why?
|
Lipid Metabolism | 2 | 2019 | 1892 | 0.170 |
Why?
|
Medical Record Linkage | 1 | 2021 | 283 | 0.170 |
Why?
|
Vasculitis | 1 | 2024 | 522 | 0.170 |
Why?
|
Comorbidity | 6 | 2023 | 10567 | 0.170 |
Why?
|
Societies, Medical | 2 | 2011 | 3955 | 0.170 |
Why?
|
Incidental Findings | 1 | 2024 | 696 | 0.160 |
Why?
|
Myeloblastin | 1 | 2019 | 99 | 0.160 |
Why?
|
Veterans Health | 1 | 2021 | 216 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2016 | 12056 | 0.160 |
Why?
|
United States Department of Veterans Affairs | 1 | 2024 | 934 | 0.160 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2021 | 347 | 0.160 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1440 | 0.150 |
Why?
|
Validation Studies as Topic | 1 | 2019 | 162 | 0.150 |
Why?
|
Vital Signs | 1 | 2019 | 147 | 0.150 |
Why?
|
Anticoagulants | 1 | 2014 | 4862 | 0.150 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14745 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2024 | 1027 | 0.150 |
Why?
|
Pain, Postoperative | 1 | 2008 | 1771 | 0.150 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2685 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 583 | 0.150 |
Why?
|
United States | 16 | 2024 | 72898 | 0.150 |
Why?
|
Research Design | 4 | 2024 | 6207 | 0.140 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2019 | 283 | 0.140 |
Why?
|
Proportional Hazards Models | 6 | 2022 | 12509 | 0.140 |
Why?
|
Musculoskeletal Diseases | 1 | 2023 | 598 | 0.140 |
Why?
|
Snow | 1 | 2017 | 15 | 0.140 |
Why?
|
Stroke Volume | 2 | 2022 | 5596 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 518 | 0.130 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2019 | 214 | 0.130 |
Why?
|
Peroxidase | 1 | 2019 | 605 | 0.130 |
Why?
|
Prospective Studies | 6 | 2023 | 54795 | 0.130 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2024 | 2024 | 0.130 |
Why?
|
Likelihood Functions | 1 | 2019 | 993 | 0.130 |
Why?
|
Genetic Variation | 3 | 2024 | 6607 | 0.130 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2023 | 954 | 0.120 |
Why?
|
TYK2 Kinase | 1 | 2015 | 38 | 0.120 |
Why?
|
Retrospective Studies | 13 | 2022 | 81457 | 0.120 |
Why?
|
Boston | 4 | 2017 | 9337 | 0.120 |
Why?
|
Medical Informatics Applications | 1 | 2016 | 180 | 0.120 |
Why?
|
Neoplasms | 2 | 2014 | 22345 | 0.120 |
Why?
|
Skin Diseases | 1 | 2023 | 1080 | 0.120 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15883 | 0.120 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 3446 | 0.110 |
Why?
|
Rectal Fistula | 1 | 2014 | 76 | 0.110 |
Why?
|
Lymphoma | 1 | 2023 | 1896 | 0.110 |
Why?
|
Creatinine | 1 | 2019 | 1915 | 0.110 |
Why?
|
Genetic Pleiotropy | 1 | 2015 | 182 | 0.110 |
Why?
|
Aortic Aneurysm | 1 | 2018 | 623 | 0.110 |
Why?
|
Probability | 1 | 2018 | 2473 | 0.100 |
Why?
|
Scleroderma, Systemic | 1 | 2017 | 345 | 0.100 |
Why?
|
Pleurisy | 1 | 2013 | 53 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2538 | 0.100 |
Why?
|
Multiple Sclerosis | 2 | 2021 | 3213 | 0.100 |
Why?
|
Thyroiditis | 1 | 2013 | 85 | 0.100 |
Why?
|
Biometry | 1 | 2016 | 571 | 0.100 |
Why?
|
Aged, 80 and over | 8 | 2021 | 59459 | 0.100 |
Why?
|
Positron-Emission Tomography | 3 | 2024 | 6546 | 0.100 |
Why?
|
Treatment Outcome | 5 | 2024 | 65180 | 0.100 |
Why?
|
B-Lymphocytes | 2 | 2023 | 4779 | 0.100 |
Why?
|
Propensity Score | 1 | 2019 | 1968 | 0.100 |
Why?
|
Primary Prevention | 1 | 2019 | 1187 | 0.100 |
Why?
|
Transglutaminases | 1 | 2013 | 201 | 0.090 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 26284 | 0.090 |
Why?
|
Prevalence | 3 | 2021 | 15833 | 0.090 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 404 | 0.090 |
Why?
|
Bacterial Infections | 1 | 2019 | 1387 | 0.090 |
Why?
|
Iodide Peroxidase | 1 | 2013 | 295 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2016 | 3251 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2023 | 2531 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3432 | 0.090 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 520 | 0.090 |
Why?
|
Nutrition Surveys | 1 | 2018 | 1741 | 0.090 |
Why?
|
Managed Care Programs | 1 | 2016 | 934 | 0.090 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 416 | 0.090 |
Why?
|
Laparoscopy | 1 | 2022 | 2039 | 0.090 |
Why?
|
Postoperative Complications | 1 | 2013 | 15749 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3709 | 0.090 |
Why?
|
Medicare | 3 | 2023 | 6821 | 0.080 |
Why?
|
Sweden | 2 | 2013 | 1381 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1945 | 0.080 |
Why?
|
Peripheral Arterial Disease | 1 | 2021 | 1311 | 0.080 |
Why?
|
Time Factors | 4 | 2018 | 40066 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2012 | 640 | 0.080 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2014 | 698 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 932 | 0.080 |
Why?
|
Digestive System Surgical Procedures | 1 | 2014 | 580 | 0.080 |
Why?
|
Research | 2 | 2023 | 1975 | 0.080 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 944 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13448 | 0.080 |
Why?
|
Young Adult | 11 | 2022 | 59852 | 0.080 |
Why?
|
Linear Models | 2 | 2018 | 5876 | 0.080 |
Why?
|
Gene Frequency | 2 | 2012 | 3623 | 0.080 |
Why?
|
ROC Curve | 4 | 2024 | 3618 | 0.070 |
Why?
|
Chronic Disease | 2 | 2021 | 9351 | 0.070 |
Why?
|
Inpatients | 1 | 2019 | 2564 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11504 | 0.070 |
Why?
|
Odds Ratio | 3 | 2015 | 9647 | 0.070 |
Why?
|
Adolescent | 11 | 2017 | 88781 | 0.070 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 888 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3593 | 0.070 |
Why?
|
Models, Statistical | 3 | 2017 | 5088 | 0.070 |
Why?
|
Autoimmunity | 1 | 2015 | 1354 | 0.070 |
Why?
|
Contraceptives, Oral | 1 | 2009 | 559 | 0.070 |
Why?
|
Genetic Loci | 2 | 2015 | 2631 | 0.070 |
Why?
|
Azathioprine | 2 | 2019 | 350 | 0.070 |
Why?
|
Disease Management | 2 | 2015 | 2534 | 0.070 |
Why?
|
Stroke | 2 | 2021 | 9747 | 0.060 |
Why?
|
Smith-Lemli-Opitz Syndrome | 1 | 2006 | 46 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2017 | 2968 | 0.060 |
Why?
|
Meat | 1 | 2009 | 588 | 0.060 |
Why?
|
Smoking | 3 | 2013 | 9077 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2015 | 2185 | 0.060 |
Why?
|
Drug Discovery | 1 | 2013 | 1063 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4207 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3592 | 0.060 |
Why?
|
Cell Degranulation | 1 | 2006 | 280 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1458 | 0.060 |
Why?
|
Dyspnea | 1 | 2013 | 1352 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6319 | 0.060 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2006 | 172 | 0.060 |
Why?
|
Hypertension | 2 | 2016 | 8626 | 0.060 |
Why?
|
Models, Genetic | 1 | 2014 | 3447 | 0.060 |
Why?
|
Sex Factors | 2 | 2021 | 10605 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6499 | 0.060 |
Why?
|
Knowledge Bases | 1 | 2024 | 96 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5188 | 0.050 |
Why?
|
Leg | 1 | 2008 | 1080 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2018 | 3989 | 0.050 |
Why?
|
Informatics | 1 | 2023 | 71 | 0.050 |
Why?
|
Logical Observation Identifiers Names and Codes | 1 | 2022 | 16 | 0.050 |
Why?
|
Lung Diseases | 1 | 2013 | 1940 | 0.050 |
Why?
|
Computer Simulation | 4 | 2019 | 6252 | 0.050 |
Why?
|
Whole Body Imaging | 1 | 2024 | 281 | 0.050 |
Why?
|
Cluster Analysis | 2 | 2019 | 2720 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2822 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3230 | 0.050 |
Why?
|
Cyclophosphamide | 2 | 2019 | 2227 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
Sample Size | 2 | 2016 | 843 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2016 | 4301 | 0.050 |
Why?
|
Computational Biology | 3 | 2024 | 3558 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2009 | 2740 | 0.050 |
Why?
|
Massachusetts | 1 | 2014 | 8876 | 0.040 |
Why?
|
Birth Weight | 1 | 2009 | 2121 | 0.040 |
Why?
|
Breast Feeding | 1 | 2009 | 1363 | 0.040 |
Why?
|
Calibration | 1 | 2023 | 814 | 0.040 |
Why?
|
Alcohol Drinking | 2 | 2013 | 4041 | 0.040 |
Why?
|
Patient Readmission | 1 | 2014 | 3286 | 0.040 |
Why?
|
Social Class | 1 | 2009 | 2007 | 0.040 |
Why?
|
Research Personnel | 1 | 2024 | 590 | 0.040 |
Why?
|
Survival Rate | 1 | 2014 | 12787 | 0.040 |
Why?
|
Health Surveys | 1 | 2009 | 4057 | 0.040 |
Why?
|
Mast Cells | 1 | 2006 | 1411 | 0.040 |
Why?
|
Disclosure | 1 | 2024 | 756 | 0.040 |
Why?
|
Osteoarthritis | 2 | 2016 | 1050 | 0.040 |
Why?
|
Pregnancy | 3 | 2015 | 30248 | 0.040 |
Why?
|
Biological Assay | 1 | 2021 | 627 | 0.040 |
Why?
|
Exons | 2 | 2015 | 2391 | 0.040 |
Why?
|
Current Procedural Terminology | 1 | 2018 | 100 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9441 | 0.040 |
Why?
|
Europe | 2 | 2017 | 3423 | 0.030 |
Why?
|
Automation | 1 | 2019 | 585 | 0.030 |
Why?
|
Colectomy | 1 | 2022 | 697 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2223 | 0.030 |
Why?
|
Documentation | 1 | 2023 | 916 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2006 | 1168 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2021 | 988 | 0.030 |
Why?
|
Age Factors | 3 | 2021 | 18375 | 0.030 |
Why?
|
Penicillamine | 1 | 2016 | 59 | 0.030 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 2033 | 0.030 |
Why?
|
Hemoglobins | 1 | 2022 | 1528 | 0.030 |
Why?
|
Pattern Recognition, Automated | 1 | 2022 | 979 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 790 | 0.030 |
Why?
|
Minocycline | 1 | 2016 | 168 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2699 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 8062 | 0.030 |
Why?
|
Confidentiality | 1 | 2019 | 607 | 0.030 |
Why?
|
Lung | 1 | 2013 | 10031 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2009 | 4542 | 0.030 |
Why?
|
Mass Screening | 1 | 2009 | 5445 | 0.030 |
Why?
|
Genetic Research | 1 | 2014 | 173 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12949 | 0.030 |
Why?
|
Cold Temperature | 1 | 2017 | 794 | 0.030 |
Why?
|
Medical Audit | 1 | 2014 | 452 | 0.030 |
Why?
|
Japan | 1 | 2017 | 1415 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2012 | 14 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2021 | 2586 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2022 | 4249 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 2896 | 0.020 |
Why?
|
Outpatients | 1 | 2020 | 1594 | 0.020 |
Why?
|
Republic of Korea | 1 | 2014 | 588 | 0.020 |
Why?
|
Drug Repositioning | 1 | 2013 | 245 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 608 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2023 | 4494 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 744 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3926 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2354 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1657 | 0.020 |
Why?
|
Survival Analysis | 1 | 2023 | 10069 | 0.020 |
Why?
|
Acute-Phase Reaction | 1 | 2010 | 90 | 0.020 |
Why?
|
Ikaros Transcription Factor | 1 | 2012 | 230 | 0.020 |
Why?
|
Clinical Chemistry Tests | 1 | 2010 | 59 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 13079 | 0.020 |
Why?
|
Heart | 1 | 2023 | 4417 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 574 | 0.020 |
Why?
|
Parity | 1 | 2013 | 931 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20120 | 0.020 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2010 | 147 | 0.020 |
Why?
|
Drug Utilization | 1 | 2015 | 1187 | 0.020 |
Why?
|
Proteins | 1 | 2024 | 5996 | 0.020 |
Why?
|
Hospital Information Systems | 1 | 2012 | 396 | 0.020 |
Why?
|
Neprilysin | 1 | 2012 | 484 | 0.020 |
Why?
|
Synovitis | 1 | 2010 | 209 | 0.020 |
Why?
|
Accidental Falls | 1 | 2017 | 1078 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1610 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2441 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7424 | 0.020 |
Why?
|
Health | 1 | 2011 | 397 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8498 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5074 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1692 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3800 | 0.020 |
Why?
|
Calcium | 1 | 2020 | 5765 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1996 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7066 | 0.020 |
Why?
|
North America | 1 | 2010 | 1285 | 0.020 |
Why?
|
Dehydrocholesterols | 1 | 2006 | 20 | 0.020 |
Why?
|
Syndrome | 1 | 2013 | 3268 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1807 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2006 | 130 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10262 | 0.020 |
Why?
|
Peptides | 1 | 2018 | 4331 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2513 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2013 | 14445 | 0.010 |
Why?
|
Membrane Microdomains | 1 | 2006 | 203 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15390 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3339 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2511 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1432 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2006 | 538 | 0.010 |
Why?
|
Body Mass Index | 1 | 2021 | 13044 | 0.010 |
Why?
|
Medicaid | 1 | 2016 | 2833 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2010 | 1535 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 3109 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2012 | 7849 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10385 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6917 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1926 | 0.010 |
Why?
|
Nurses | 1 | 2011 | 2505 | 0.010 |
Why?
|
Consensus | 1 | 2010 | 3200 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2010 | 2002 | 0.010 |
Why?
|
Protein Transport | 1 | 2006 | 1937 | 0.010 |
Why?
|
Software | 1 | 2014 | 4459 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9245 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42468 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3684 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 1959 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20667 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2006 | 2445 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8279 | 0.010 |
Why?
|
Mice | 2 | 2013 | 81792 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2006 | 18972 | 0.010 |
Why?
|
Animals | 2 | 2013 | 168731 | 0.000 |
Why?
|
Child | 1 | 2015 | 80499 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18289 | 0.000 |
Why?
|